Praxis Precision Medicines Inc (PRAX) — Long-term Investment Intensity

Latest as of March 2026: 45.3%

Praxis Precision Medicines Inc (PRAX) has a Long-term Investment Intensity of 45.3% as of March 2026. Long-term investments of $660.94 Million represent 45.3% of total assets of $1.46 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Praxis Precision Medicines Inc (PRAX) asset resilience to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

45.3%
LT Investments / Total Assets

Long-term Investments

$660.94 Million
USD

Total Assets

$1.46 Billion
USD

Country

USA
NASDAQ

Praxis Precision Medicines Inc Long-term Investment Intensity (2024–2025)

This chart shows how Praxis Precision Medicines Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the intensity stands at 45.3%, reflecting long-term investments of $660.94 Million against total assets of $1.46 Billion USD. For the complete balance sheet picture, see PRAX current and non-current assets.

Annual Long-term Investment Intensity for Praxis Precision Medicines Inc (2024–2025)

The table below presents the year-by-year Long-term Investment Intensity for Praxis Precision Medicines Inc from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Praxis Precision Medicines Inc debt and liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 34.8% $326.76 Million $937.91 Million ▲ +18.9 pp
2024 15.9% $76.96 Million $483.11 Million
pp = percentage points